Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024-09 · 22 (7) · 483-506
DOI: 10.6004/jnccn.2024.0046 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-09. Verfasst von Michael B Streiff und 33 weiteren Autor:innen. Beteiligte Einrichtung: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Hauptthemen laut MEDLINE: Venous Thromboembolism, Neoplasms. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 266 Literaturangaben.
Abstract (Originalsprache)
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Moffitt Cancer Center.
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
- Mayo Clinic Comprehensive Cancer Center.
- University of Colorado Cancer Center.
- Stanford Cancer Institute.
Zitieren
APA
Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Buckner, T., Diep, R., Fertrin, K. Y., Fogerty, A. E., Crestani, N. G., Gangaraju, R., Rojas-Hernandez, C., Goldhaber, S. Z., Ibrahim, I., Kubal, T., Leavitt, A. D., Lim, M., Mann, J., Mantha, S., Morton, C., …, & Sliker, B. (2024). Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(7), 483-506. https://doi.org/10.6004/jnccn.2024.0046
Vancouver
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2024;22(7):483-506. doi:10.6004/jnccn.2024.0046
BibTeX
@article{Streiff2024,
author = {Streiff, Michael B and Holmstrom, Bjorn and Angelini, Dana and Ashrani, Aneel and Buckner, Tyler and Diep, Robert and Fertrin, Kleber Yotsumoto and Fogerty, Annemarie E and Crestani, Nicolas Gallastegui and Gangaraju, Radhika and Rojas-Hernandez, Cristhiam and Goldhaber, Samuel Z and Ibrahim, Ibrahim and Kubal, Timothy and Leavitt, Andrew D and Lim, Ming and Mann, Janelle and Mantha, Simon and Morton, Colleen and Nester, Alex and O'Brien, Andrew and Ortel, Thomas L and Pine, Alexander and Pishko, Allyson and Ranade, Mona and Salmasi, Amirali and Schaefer, Jordan and Williams, Eliot and Wool, Geoffrey and Wun, Theodore and Montgomery, Sarah and Nguyen, Jamie and Freedman-Cass, Deborah and Sliker, Bailee},
title = {Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {7},
pages = {483--506},
doi = {10.6004/jnccn.2024.0046}
}
EUVIMED